Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
27,615,000
Number of holders
13
Total 13F shares, excl. options
8,090,280
Shares change
-448,363
Total reported value, excl. options
$2,264,622
Value change
-$123,935
Number of buys
4
Number of sells
-4
Price
$0.2800

Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q4 2023

14 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q4 2023.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8,090,280 shares of 27,615,000 outstanding shares and own 29.3% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4,517,589 shares), JOHNSON & JOHNSON (2,133,402 shares), 8VC GP I, LLC (1,086,191 shares), RENAISSANCE TECHNOLOGIES LLC (110,294 shares), MMCAP International Inc. SPC (96,805 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (49,500 shares), CITADEL ADVISORS LLC (33,582 shares), Walleye Capital LLC (21,056 shares), XTX Topco Ltd (14,531 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (10,908 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.